AtriCure (ATRC) Net Cash Flow (2010 - 2026)

AtriCure (ATRC) has 17 years of Net Cash Flow data on file, last reported at -$21.1 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$21.1 million, up 8.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.9 million (up 30.97% YoY), and the FY2025 annual result was $44.0 million, up 13.2% from the prior year.
• Net Cash Flow declined to -$21.1 million in Q1 2026 per ATRC's latest filing, from $19.5 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $41.1 million in Q2 2024 and troughed at -$23.0 million in Q1 2025.
• A 5-year average of $6.0 million and a median of $9.0 million in 2022 frame the typical range for Net Cash Flow.
• On a YoY basis, Net Cash Flow climbed as much as 508.19% in 2024 and fell as far as 297.59% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $9.0 million in 2022, then slumped by 60.1% to $3.6 million in 2023, then slumped by 297.59% to -$7.1 million in 2024, then soared by 374.24% to $19.5 million in 2025, then sank by 208.09% to -$21.1 million in 2026.
• Business Quant data shows ATRC's Net Cash Flow at -$21.1 million in Q1 2026, $19.5 million in Q4 2025, and $30.1 million in Q3 2025.